Morphic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Morphic and buy or sell other stocks, ETFs, and their options commission-free!

About MORF

Morphic Holding, Inc., operates as a biopharmaceutical company, which researches and develops oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. 

CEO
Praveen P. Tipirneni, MD, MBA
CEOPraveen P. Tipirneni, MD, MBA
Employees
Employees
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2014
Founded2014
Employees
Employees

MORF Key Statistics

Market cap
2.86B
Market cap2.86B
Price-Earnings ratio
-15.81
Price-Earnings ratio-15.81
Dividend yield
Dividend yield
Average volume
538.29K
Average volume538.29K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$57.00
52 Week high$57.00
52 Week low
$19.35
52 Week low$19.35
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.